Drug
Eldecalcitol
Eldecalcitol: highest development phase Post-Market, developed by Chugai. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Eldecalcitol NCT05884372 | Post-Market | Osteoporosis in Postmenopausal Women |
| Eldecalcitol capsules NCT05902078 | Post-Market | Low Bone Mineral Density |
Latest
No recent events.
Follow Eldecalcitol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.